BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 2205945)

  • 1. Graft-versus-host disease of the intestine.
    Cox GJ; McDonald GB
    Springer Semin Immunopathol; 1990; 12(2-3):283-99. PubMed ID: 2205945
    [No Abstract]   [Full Text] [Related]  

  • 2. Intestinal and hepatic complications of human bone marrow transplantation. Part I.
    McDonald GB; Shulman HM; Sullivan KM; Spencer GD
    Gastroenterology; 1986 Feb; 90(2):460-77. PubMed ID: 3510147
    [No Abstract]   [Full Text] [Related]  

  • 3. Helper T-lymphocyte precursor frequencies predict risks of graft-versus-host disease in bone marrow transplantation.
    Batchelor JR; Schwarer AP; Yin ZJ; Barrett AJ; Goldman JM; Lechler RI
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1237-8. PubMed ID: 8442100
    [No Abstract]   [Full Text] [Related]  

  • 4. Intestinal and hepatic complications of human bone marrow transplantation. Part II.
    McDonald GB; Shulman HM; Sullivan KM; Spencer GD
    Gastroenterology; 1986 Mar; 90(3):770-84. PubMed ID: 3510940
    [No Abstract]   [Full Text] [Related]  

  • 5. Stool smears for diagnosis of intestinal acute graft-versus-host disease.
    Hirano K; Kondo F; Kondo Y; Kurosawa K; Suwabe S; Noguchi Y; Miura N; Kakuda H; Sato T; Niimi H
    Bone Marrow Transplant; 1999 Oct; 24(7):799-801. PubMed ID: 10516685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplantation and graft-versus-host disease.
    Powles RL
    Curr Opin Immunol; 1989-1990; 2(6):870-5. PubMed ID: 2486567
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute Graft-versus-Host Disease: Novel Biological Insights.
    Teshima T; Reddy P; Zeiser R
    Biol Blood Marrow Transplant; 2016 Jan; 22(1):11-6. PubMed ID: 26453971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute GVHD: pathogenesis, symptomatology, stage/severity, and treatment].
    Imamura M; Miyazaki T; Kasai M
    Nihon Rinsho; 1990 Sep; 48(9):2055-60. PubMed ID: 2232210
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings.
    Johnsen HE
    N Engl J Med; 1993 May; 328(20):1497-8. PubMed ID: 8479479
    [No Abstract]   [Full Text] [Related]  

  • 10. [Bone marrow transplantation in chronic myeloid leukemia].
    Hansz J
    Acta Haematol Pol; 1992; 23(2 Suppl 1):38-48. PubMed ID: 1488871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-DP incompatibilities and severe graft-versus-host disease in unrelated bone marrow transplants.
    Kato Y; Mitsuishi Y; Cecka M; Hopfield J; Hunt L; Champlin R; Terasaki PI; Gajewski JL
    Transplantation; 1991 Aug; 52(2):374-6. PubMed ID: 1871811
    [No Abstract]   [Full Text] [Related]  

  • 12. Selection of marrow donors for patients lacking an HLA-identical sibling.
    Anasetti C; Beatty PG
    Cancer Treat Res; 1990; 50():129-40. PubMed ID: 1976347
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunopathogenesis and clinical aspects of chronic GVHD after allogeneic bone marrow transplantation].
    Kubo K
    Nihon Rinsho; 1990 Sep; 48(9):2061-7. PubMed ID: 2232211
    [No Abstract]   [Full Text] [Related]  

  • 14. Bone marrow transplantation utilizing HLA-matched unrelated marrow donors.
    Gajewski J; Cecka M; Champlin R
    Blood Rev; 1990 Jun; 4(2):132-8. PubMed ID: 2194597
    [No Abstract]   [Full Text] [Related]  

  • 15. Significance of MLC for BMT with serological HLA-identical related and unrelated donors.
    Bonfichi M; Bernasconi P; Brera C; Boni M; Caldera C; Campagnoli C; Alessandrino EP; Bernasconi C
    Bone Marrow Transplant; 1993; 11 Suppl 1():28-30. PubMed ID: 8448540
    [No Abstract]   [Full Text] [Related]  

  • 16. Predicting graft-versus-host disease.
    Theobald M
    Curr Opin Immunol; 1995 Oct; 7(5):649-55. PubMed ID: 8573308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.
    Brown GR; Lee E; Thiele DL
    J Immunol; 2002 Mar; 168(6):3065-71. PubMed ID: 11884480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow augmentation of kidney allografts can cause graft-versus-host disease in immunosuppressed recipients.
    Pirenne J; Moon C; Gruessner A; Benedetti E; Nakhleh RE; Uckun F; Gruessner RW
    Transplant Proc; 1996 Apr; 28(2):941-2. PubMed ID: 8623472
    [No Abstract]   [Full Text] [Related]  

  • 19. Graft-versus-host disease.
    Nijhawan A; Drolet BA
    Adv Dermatol; 2001; 17():115-39. PubMed ID: 11758114
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient.
    Spaner D; Lowsky R; Fyles G; Lipton JH; Banerjee D; Ng CM; Wade JA; Messner HA
    Transplantation; 1998 Nov; 66(9):1251-3. PubMed ID: 9825825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.